|
ZNF174 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.600600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.321000E-01 |
| Normal-vs-Stage2 |
2.166800E-01 |
| Normal-vs-Stage3 |
4.367800E-01 |
| Normal-vs-Stage4 |
3.516400E-01 |
| Stage1-vs-Stage2 |
1.543740E-02 |
| Stage1-vs-Stage3 |
8.605400E-01 |
| Stage1-vs-Stage4 |
6.948400E-01 |
| Stage2-vs-Stage3 |
3.325600E-02 |
| Stage2-vs-Stage4 |
3.280400E-02 |
| Stage3-vs-Stage4 |
8.258800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.232000E-01 |
| Normal-vs-AfricanAmerican |
6.787400E-01 |
| Normal-vs-Asian |
8.844800E-01 |
| Caucasian-vs-AfricanAmerican |
3.557000E-01 |
| Caucasian-vs-Asian |
5.703200E-01 |
| AfricanAmerican-vs-Asian |
5.316200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.095600E-01 |
| Normal-vs-Female |
4.597400E-01 |
| Male-vs-Female |
3.919400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.374400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.753600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.854200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.553550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.383200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.451000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.004200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.643600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.574820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.330240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.678000E-02 |
| Classical-VS-Follicular |
8.926000E-01 |
| Classical-VS-Other |
3.088600E-01 |
| Classical-VS-Normal |
8.298400E-01 |
| Tall-VS-Follicular |
6.669800E-02 |
| Tall-VS-Other |
9.658800E-01 |
| Tall-VS-Normal |
9.278400E-02 |
| Follicular-VS-Other |
3.969800E-01 |
| Follicular-VS-Normal |
9.486200E-01 |
| Other-VS-Normal |
3.351200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.844000E-01 |
| Normal-vs-N1 |
1.532250E-02 |
| N0-vs-N1 |
5.403300E-04 |
|
|
